| HCV-RNA (TMA) | sustained responder to therapy | sustained non-responder | ||
No. | total | No. | total | ||
At week 24 | negative | 41/49 (83.7%) | 41/54 (75.9%) | 8/49 (16.3%) | 13/54 (24.07%) |
positive | 0/5 | 5/5 (100%) | |||
At week 48 | negative | 41/47 (87.2%) | 41/54 (75.9%) | 6/47 (12.8%) | 13/54 (24.07%) |
positive | 0/7 | 7/7 (100%) | |||
At week 72 | negative | 40/40 (100%) | 40/49 (86.9%) | 0/40 | 6/46 (13.04%) |
positive | 0/6 | 6/6 (100%) |